AI assistant
DEXCOM INC — Director's Dealing 2013
Nov 13, 2013
30198_dirs_2013-11-13_0eaab9e4-1853-44a2-a515-f3ebbac5cb0b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2013-11-12
Reporting Person: VALDES JORGE A (CTO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-11-12 | Common Stock | S | 26600.0 | $33.3433 | Disposed | 144853 | Direct |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $33.30 to $33.57. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected.
F2: Included in this number are 119,429 unvested restricted stock units, 71,621 of which were granted on March 11, 2013 and shall vest through March 11, 2016, 35,811 of which were granted on March 8, 2012 and shall vest through March 8, 2015 and 11,997 of which were granted on March 8, 2011 and shall vest through March 8, 2014.